• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Microbiome Times

Finance

Intralytix, Eliava Foundation and Ferring Sign Joint Collaboration Agreement

June 17, 2019 Microbiome Times

Intralytix, Inc., announced today that is has entered into a joint collaboration agreement with the Eliava Foundation and Ferring Pharmaceuticals to develop and commercialize new and innovative bacteriophage-based drugs in the field of Reproductive Medicine […]

Pharma & Human Health

FDA Issues Important Safety Alert for Use of FMT after Serious Adverse Reactions

June 15, 2019 Microbiome Times

The Food and Drug Administration (FDA) issued an Important Safety Alert regarding the use of FMT and risk of serious adverse reactions due to transmission of Multi-Drug Resistant Organisms. The Alert was issued after two immunocompromised adults […]

Pharma & Human Health

Bacterial chemical ‘signatures’ a sign of damaged gut microbiome in critical illness

June 14, 2019 Microbiome Times

Chemicals produced by healthy bacteria could be used to assess the health of the gut microbiome and help identify critically-ill children at greatest risk of organ failure, a study published in Critical Care Medicine has […]

Finance

Synlogic and Ginkgo Bioworks Establish Transformational Platform Collaboration for GMO Microorganisms

June 13, 2019 Microbiome Times

Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage company applying synthetic biology to beneficial microbes to develop novel, living medicines and Ginkgo Bioworks, the organism company, today announced a platform collaboration to accelerate expansion and development of […]

Editor's Choice

Webinar: Improving Ulcerative Colitis Symptoms with Probiotics

June 12, 2019 Microbiome Times

  Speakers: Thomas Tompkins, R&D Manager & Ghania Sohail, Clinical Research Associate – Rosell Institute for Microbiome & Probiotics by Lallemand

Finance

BiomX Licenses Novel Targets for Liver Disease Phage Therapy Program From JSR Corporation

June 12, 2019 Microbiome Times

BiomX Ltd., a microbiome company developing both natural and engineered phage therapies, today announced it has licensed a new set of bacterial targets from JSR Corporation, for the development and commercialization of phage therapies for […]

Pharma & Human Health

Just a phage? How bacteria’s predators can shape the gut microbiome

June 8, 2019 Microbiome Times

The gut microbiome is a complex, interconnected ecosystem of species. And, like any ecosystem, some organisms are predators and some are prey. A new study led by investigators at Brigham and Women’s Hospital and the […]

Editor's Choice

Investing in the Microbiome: A discussion between Isabelle de Cremoux & Malcolm Kendall

June 5, 2019 Microbiome Times
Pharma & Human Health

Labels of US Probiotic Products Lacking, Researchers Find

June 5, 2019 Microbiome Times

When it comes to buying probiotics, many product labels do not give consumers enough information to make an informed decision, according to a research team led by Georgetown University Medical Center. In their study, published […]

Editor's Choice

Gut check: Yale researchers describe role of bacteria in drug response

June 4, 2019 Microbiome Times

Yale researchers identified human gut microbes that metabolize over 150 therapeutic drugs, a finding that highlights the role bacteria play in determining how well individuals respond to medications, they report June 3 in the journal […]

Pharma & Human Health

Expert panel calls for increased transparency so consumers can identify quality probiotics

June 3, 2019 Microbiome Times

Probiotics are increasingly being researched and marketed as functional ingredients to enhance health. As the market for these products grows, consumers face difficulty in distinguishing between high- and low-quality products. In the current context, is […]

Posts navigation

« 1 … 52 53 54 … 78 »

Sign Up to Free Newsletter

NEW WHITEPAPER: ORAL DELIVERY OF LIVE BIOTHERAPEUTIC PRODUCTS:

Editor’s Choice

  • Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study
    November 17, 2025
  • The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies
    November 12, 2025
  • MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
    September 4, 2025
  • Targeting the ileo-colonic region: Innovative solutions for sensitive APIs
    August 21, 2025
  • EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
    June 23, 2025
sign up

Sign up to the Microbiome Times newsletter